CDKN2A and fibrosarcoma: TYMS expression in these mice did not increase the overall incidence of fibrosarcoma, although we observed 2-fold higher fibrosarcoma incidence in hTS/Ink4a/Arf−/− females compared to control Ink4a/Arf−/− females (15.2% vs 7.1% respectively).